Education
About Us
Working with TipRanks
Follow Us
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
Aridis Pharmaceuticals (ARDS) is scheduled to report 4th quarter earnings on 03/30/2023. Regarding Q4 estimates, Wall Street analysts expect Aridis Pharmaceuticals to post earnings of -$0.41 per share. Revenue expectations
...Read more
ARDS News on the Web
Zacks
Neutral
TipRanks News
Bullish
TipRanks News
Bullish
InvestorPlace
Neutral
Zacks
Neutral
Zacks
Neutral
Zacks
Neutral
InvestorPlace
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
FAQ
What is ARDS’s Media Buzz Sentiment?
Currently, no data Available
What is ARDS’s weekly average amount of articles?
Currently, no data Available
What is ARDS’s News Sentiment?
Currently, no data Available